Significant findings in U.S. national institutes of health's trial of Pluristem's PLX-R18 cells for treatment of acute radiation syndrome
Medical News Today,
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, has announced the positive results of…